CSPC Pharmaceutical Group Limited — Earnings Release 2005

Dec 7, 2005

Listed Company Information

Listed Company Information
CHINA PHARMA<01093> - Results Announcement China Pharmaceutical Group Limited announced on 07/12/2005: (stock code: 01093 ) Year end date: 31/12/2005 Currency: HKD Auditors' Report: N/A Interim/Quarterly report reviewed by: Both Audit Committee and Auditors (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/01/2005 from 01/01/2004 to 30/09/2005 to 30/09/2004 Note ('000 ) ('000 ) Turnover : 2,288,276 1,710,887 Profit/(Loss) from Operations : 177,047 218,499 Finance cost : (46,040) (17,209) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : (543) 2,655 Profit/(Loss) after Tax & MI : 123,847 184,926 % Change over Last Period : -33 % EPS/(LPS)-Basic (in dollars) : 0.0805 0.1202 -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 123,847 184,926 3rd Quarter Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for 3rd Quarter Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. The accounting policies adopted are consistent with those disclosed in the 2005 interim report of the Company. 2. The calculation of the basic earnings per share for the nine months ended September 30, 2005 is based on the profit attributable to equity holders of the Company of HK$123,847,000 (2004: HK$184,926,000) and 1,538,124,661 shares (2004: 1,538,124,661 shares) in issue during the period. No diluted earnings per share is presented for the nine months ended September 30, 2005 and 2004 as there was no potential ordinary share in issue during the periods. 3. The comparative figure for share of (loss) profit of a jointly controlled entity has been changed to include the Company's share of taxation of the jointly controlled entity.